Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pegylated recombinant Erwinia chrysanthemi L-asparaginase

EU orphan designation number: EU/3/11/889   
Active ingredient: Pegylated recombinant Erwinia chrysanthemi L-asparaginase
Indication: Treatment of acute lymphoblastic leukaemia
Sponsor: EUSA Pharma SAS
3 allée des Séquoias, F-69760 Limonest, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/08/2011 Orphan Designation EMA/OD/168/10 (2011)5814 of 05/08/2011
23/03/2012 Transfer of orphan designation EMA/OD/168/10/T/01 (2012)2020 of 21/03/2012